Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126119171 | 12611917 | 1 | I | 20160304 | 20160801 | 20160801 | PER | US-PFIZER INC-3204431 | PFIZER | 0.00 | Y | 0.00000 | 20160801 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126119171 | 12611917 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | U | UNK | 11719 | ||||||||||
126119171 | 12611917 | 2 | SS | ANAKINRA | ANAKINRA | 1 | U | UNK | 0 | ||||||||||
126119171 | 12611917 | 3 | SS | CANAKINUMAB | CANAKINUMAB | 1 | U | UNK | 0 | ||||||||||
126119171 | 12611917 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | U | UNK | 0 | ||||||||||
126119171 | 12611917 | 5 | SS | TOCILIZUMAB | TOCILIZUMAB | 1 | Intravenous drip | U | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126119171 | 12611917 | 1 | Still's disease adult onset |
126119171 | 12611917 | 2 | Still's disease adult onset |
126119171 | 12611917 | 3 | Still's disease adult onset |
126119171 | 12611917 | 4 | Still's disease adult onset |
126119171 | 12611917 | 5 | Still's disease adult onset |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126119171 | 12611917 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |